Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


13.06.2022

1 Ann Neurol
1 BMC Neurol
5 Brain
4 Intern Med
1 J Clin Endocrinol Metab
2 J Neuroimmunol
2 J Pediatr Endocrinol Metab
3 J Rheumatol
4 Mult Scler
1 Neurology
1 PLoS One
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. KOIZUMI N, Takasugi J, Ohara N, Kawamoto M, et al
    FDG-PET/CT of Giant Cell Arteritis With Normal Inflammatory Markers.
    Ann Neurol. 2022 Jun 6. doi: 10.1002/ana.26428.
    PubMed        


    BMC Neurol

  2. FOX RJ, Mehta R, Pham T, Park J, et al
    Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis.
    BMC Neurol. 2022;22:211.
    PubMed         Abstract available


    Brain

  3. RUCK T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, et al
    Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
    Brain. 2022;145:1711-1725.
    PubMed         Abstract available

  4. BRADL M
    From astrocyte destruction to axon injury: watching lesion evolution in experimental neuromyelitis optica.
    Brain. 2022;145:1581-1583.
    PubMed        

  5. HERWERTH M, Kenet S, Schifferer M, Winkler A, et al
    A new form of axonal pathology in a spinal model of neuromyelitis optica.
    Brain. 2022;145:1726-1742.
    PubMed         Abstract available

  6. ADRICHEM ME, Lucke IM, Vrancken AFJE, Goedee HS, et al
    Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Brain. 2022;145:1641-1652.
    PubMed         Abstract available

  7. COLES A
    Campath, clones and the cause of autoimmunity.
    Brain. 2022;145:1579-1580.
    PubMed        


    Intern Med

  8. YOKOTE A, Fujioka S, Takahashi N, Mishima T, et al
    Polymyalgia Rheumatica Following COVID-19 Vaccination.
    Intern Med. 2022;61:1775-1777.
    PubMed         Abstract available

  9. TSUKAMOTO Y, Umeda M, Muto Y, Sugimoto T, et al
    Severe Anemia Due to Cold Agglutinin Syndrome in a COVID-19 Patient with IgM Monoclonal Gammopathy of Undetermined Significance Successfully Treated with Corticosteroids.
    Intern Med. 2022;61:1789-1793.
    PubMed         Abstract available

  10. TAMANOI D, Saruwatari K, Imamura K, Sato R, et al
    Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy.
    Intern Med. 2022;61:1731-1734.
    PubMed         Abstract available

  11. KUNII E, Owaki S, Yamada K, Yoshihara M, et al
    Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.
    Intern Med. 2022;61:1739-1742.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  12. LUI DTW, Lee CH, Cheung CYY, Cheung Mak JH, et al
    Impact of COVID-19 vaccines on thyroid function and autoimmunity and impact of thyroid autoimmunity on antibody response.
    J Clin Endocrinol Metab. 2022 Jun 9. pii: 6604853. doi: 10.1210.
    PubMed         Abstract available


    J Neuroimmunol

  13. MURAKAMI K, Miyamoto K, Terayama A, Yoshikawa K, et al
    Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.
    J Neuroimmunol. 2022;368:577880.
    PubMed         Abstract available

  14. DAS NEVES SP, Serre-Miranda C, Sousa JC, Costa PS, et al
    Lipocalin-2 does not influence EAE clinical score but it increases inflammation in central nervous system.
    J Neuroimmunol. 2022;368:577872.
    PubMed         Abstract available


    J Pediatr Endocrinol Metab

  15. FANTAHUN B, Leulseged TW
    Glycemic control among children with type 1 diabetes mellitus and its determinants in a resource-limited setting.
    J Pediatr Endocrinol Metab. 2022;35:813-817.
    PubMed         Abstract available

  16. PATHUM S, Viroj W
    Anxiety, pediatric type 1 diabetes and COVID-19 lockdown.
    J Pediatr Endocrinol Metab. 2022;35:819.
    PubMed        


    J Rheumatol

  17. MARINO A, Orsini F, Pregnolato F, Cimaz R, et al
    Tumor Necrosis Factor-alpha Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
    J Rheumatol. 2022;49:654-656.
    PubMed        

  18. BOLHUIS TE, Nizet LEA, Owen C, den Broeder AA, et al
    Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review.
    J Rheumatol. 2022;49:627-634.
    PubMed         Abstract available

  19. MAHESWARANATHAN M, Eudy AM, Barr AC, Howe C, et al
    Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test.
    J Rheumatol. 2022;49:585-591.
    PubMed         Abstract available


    Mult Scler

  20. AL-LOUZI O, Manukyan S, Donadieu M, Absinta M, et al
    Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study.
    Mult Scler. 2022 Jun 8:13524585221097560. doi: 10.1177/13524585221097560.
    PubMed         Abstract available

  21. SCHMIERER K, Wiendl H, Oreja-Guevara C, Centonze D, et al
    Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis.
    Mult Scler. 2022 Jun 7:13524585221099413. doi: 10.1177/13524585221099413.
    PubMed        

  22. BRUNE S, Hogestol EA, de Rodez Benavent SA, Berg-Hansen P, et al
    Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.
    Mult Scler. 2022 Jun 4:13524585221097296. doi: 10.1177/13524585221097296.
    PubMed         Abstract available

  23. LEAVITT VM, Dworkin JD, Buyukturkoglu K, Riley CS, et al
    Summary metrics of memory subnetwork functional connectivity alterations in multiple sclerosis.
    Mult Scler. 2022 Jun 4:13524585221099169. doi: 10.1177/13524585221099169.
    PubMed         Abstract available


    Neurology

  24. FREEDMAN MS, Pozzilli C, Havrdova EK, Lemle A, et al
    Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results from Randomized Phase 2b Core and Extension Studies.
    Neurology. 2022 Jun 6. pii: WNL.0000000000200606.
    PubMed         Abstract available


    PLoS One

  25. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
    PLoS One. 2022;17:e0269610.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  26. KIM S, Lu HC, Steelman AJ, Li J, et al
    Myeloid caspase-8 restricts RIPK3-dependent proinflammatory IL-1beta production and CD4 T cell activation in autoimmune demyelination.
    Proc Natl Acad Sci U S A. 2022;119:e2117636119.
    PubMed         Abstract available

  27. DAMATO V, Theorell J, Al-Diwani A, Kienzler AK, et al
    Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders.
    Proc Natl Acad Sci U S A. 2022;119:e2121804119.
    PubMed         Abstract available


  28. Correction for Chia et al., Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
    Proc Natl Acad Sci U S A. 2022;119:e2206754119.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: